Sana Biotechnology, Inc. Appoints Ke Liu, as Head of Regulatory Affairs & Strategy
January 06, 2021 at 02:00 pm
Sana Biotechnology, Inc. announced that Ke Liu, M.D., Ph.D., has joined the senior leadership team as Sana's Head of Regulatory Affairs & Strategy. Dr. Liu joins Sana after more than 17 years at the U.S. Food and Drug Administration (FDA). Dr. Liu most recently served as Associate Director for Cell and Gene Therapy at the FDA'sOncology Center of Excellence, and Chief of Oncology Branch, in the Office of Tissues and Advanced Therapies at the Center for Biologics Evaluation and Research (CBER).